Items by Bailey, Sarah

Book Sections

Bailey, S. J. and McCaffery, P. J., 2010. Vulnerability of the brain to neuropsychiatric disorders resulting from abnormal thyroid hormone or vitamin D homeostasis. In: Ritsner, M., ed. Brain Protection in Schizophrenia, Mood and Cognitive Disorders. Netherlands: Springer, pp. 105-133.

Bailey, S. J. and McCaffery, P. J., 2009. Retinoic acid signalling in neuropsychiatric disease: possible markers and treatment agents. In: Ritsner, M. S., ed. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes, and Genes. Volume III: Metabolic and Peripheral Biomarkers. Vol. 3. Netherlands: Springer, pp. 171-189.

Articles

Casal-Dominguez, J. J., Furkert, D., Ostovar, M., Teintang, L., Clarke, M. J., Traynor, J. R., Husbands, S. M. and Bailey, S. J., 2014. Forthcoming. Characterization of BU09059 : a novel potent selective κ-receptor antagonist. ACS Chemical Neuroscience

Casal-Dominguez, J. J., Clark, M., Traynor, J. R., Husbands, S. M. and Bailey, S. J., 2013. In vivo and in vitro characterization of naltrindole-derived ligands at the κ-opioid receptor. Journal of Psychopharmacology, 27 (2), pp. 192-202.

Sadler, A. and Bailey, S., 2013. The effect of chronic restraint stress on anxiety-related behaviour in the elevated plus maze. Journal of Psychopharmacology, 27 (8), A17.

Sadler, A. M. and Bailey, S. J., 2013. Forthcoming. Validation of a refined technique for taking repeated blood samples from juvenile and adult mice. Laboratory Animals

Bailey, S., Casal-Dominguez, J. and Husbands, S. M., 2012. Antidepressant effects of novel kappa-opioid receptor antagonists in the forced swim test. Journal of Psychopharmacology, 26 (8), A16.

Drew, C. J. G., O'Reilly, K. C., Lane, M. A. and Bailey, S. J., 2011. Chronic administration of 13-cis-retinoic acid does not alter the number of serotoninergic neurons in the mouse raphe nuclei. Neuroscience, 172, pp. 66-73.

Bailey, S. J., Casal-Dominguez, J. J. and Husbands, S. M., 2011. Anxiolytic effects of novel kappa-opioid receptor antagonists in the elevated plus maze. Journal of Psychopharmacology, 25 (8), A76.

Bailey, S. J., Casal-Dominguez, J. J., Bradbury, F. A., Traynor, J. R. and Husbands, S. M., 2010. In vivo characterisation of 5'-amino and amidino-alkyl, naltrindole derivatives at the kappa-opioid receptor. Journal of Psychopharmacology, 24 (Supplement 3), A42.

Trent, S., Drew, C. J. G., Mitchell, P. J. and Bailey, S. J., 2009. Chronic treatment with 13-cis-retinoic acid changes aggressive behaviours in the resident-intruder paradigm in rats. European Neuropsychopharmacology, 19 (12), pp. 876-886.

O'Reilly, K. C., Shumake, J., Bailey, S. J., Gonzalez-Lima, F. and Lane, M. A., 2009. Chronic 13-cis-retinoic acid administration disrupts network interactions between the raphe nuclei and the hippocampal system in young adult mice. European Journal of Pharmacology, 605 (1-3), pp. 68-77.

O'Reilly, K., Bailey, S. J. and Lane, M. A., 2008. Retinoid-mediated regulation of mood: Possible cellular mechanisms. Experimental Biology and Medicine, 233 (3), pp. 251-258.

O'Reilly, K. C., Bailey, S. J. and Lane, M. A., 2007. 13-Cis-retinoic acid alters serotonin reuptake transporter levels in RN46A-B14 raphe nuclei cells. FASEB Journal, 21 (6), A1178-A1178.

O'Reilly, K. C., Trent, S., Bailey, S. J. and Lane, M. A., 2007. 13-cis-retinoic acid alters intracellular serotonin, increases 5-HT1A receptor, and serotonin reuptake transporter levels in vitro. Experimental Biology and Medicine, 232, pp. 1195-1203.

Bailey, S. J., Ravier, M. A. and Rutter, G. A., 2007. Glucose-dependent regulation of γ-Aminobutyric Acid (GABAA) receptor expression in mouse pancreatic islet α-cells. Diabetes, 56 (2), pp. 320-327.

Mountjoy, P. D., Bailey, S. J. and Rutter, G. A., 2007. Inhibition by glucose or leptin of hypothalamic neurons expressing neuropeptide Y requires changes in AMP-activated protein kinase activity. Diabetologia, 50, pp. 168-177.

O'Reilly, K. C., Shumake, J., Gonzalez-Lima, F., Lane, M. A. and Bailey, S. J., 2006. Chronic administration of 13-cis-retinoic acid increases depression-related behavior in mice. Neuropsychopharmacology, 31 (9), pp. 1919-1927.

Slater, C. R., Fawcett, P. R. W., Walls, T. J., Lyons, P. R., Bailey, S. J., Beeson, D., Young, C. and Gardner-Medwin, D., 2006. Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with 'limb-girdle myasthenia'. Brain, 129, pp. 2061-2076.

Woodhall, G. L., Bailey, S. J., Thompson, S. E., Evans, D. I. P. and Jones, R. S. G., 2005. Fundamental differences in spontaneous synaptic inhibition between deep and superficial layers of the rat entorhinal cortex. Hippocampus, 15 (2), pp. 232-245.

Lane, M. A. and Bailey, S. J., 2005. Role of retinoid signalling in the adult brain. Progress in Neurobiology, 75, pp. 275-293.

Bailey, S. J., Dhillon, A., Woodhall, G. L. and Jones, R. S. G., 2004. Lamina-specific differences in GABAB autoreceptor-mediated regulation of spontaneous GABA release in rat entorhinal cortex. Neuropharmacology, 46, pp. 31-42.

Bailey, S. J. and Toth, M., 2004. Variability in the benzodiazepine response of serotonin 5-HT 1A receptor null mice displaying anxiety-lie phenotype: evidence for genetic modifiers in the 5-HT-mediated regulation of GABA A receptors. Journal of Neuroscience, 24 (28), pp. 6343-6351.

Bailey, S. J., Stocksley, M. A., Buckel, A., Young, C. and Slater, C. R., 2003. Voltage-gated sodium channels and ankyrinG occupy a different postsynaptic domain from acetylcholine receptors from an early stage of neuromuscular junction maturation in rats. Journal of Neuroscience, 23 (6), pp. 2102-2111.

Wood, S. J. and Toth, M., 2001. Molecular pathways of anxiety revealed by knockout mice. Molecular Neurobiology, 23 (2-3), pp. 101-119.

Wood, S. and Slater, C. R., 2001. Safety factor at the neuromuscular junction. Progress in Neurobiology, 64 (4), pp. 393-429.

Olivier, B., Pattij, T., Wood, S. J., Oosting, R., Sarnyai, Z. and Toth, M., 2001. The 5-HT1A receptor knockout mouse and anxiety. Behavioural Pharmacology, 12 (6-7), pp. 439-450.